Ansgar Schuffenhauer

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

Journal of cheminformatics

Journal of chemical information and modeling

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Vulpetti, Philipp Holzer, Niko Schmiedeberg, Patricia Imbach-Weese, Carole Pissot Soldermann, Gregory J Hollingworth, Thomas Radimerski, Claudio R Thoma, Therese-Marie Stachyra, Matthias Wojtynek, Magdalena Maschlej, Suzanne Chau, Ansgar Schuffenhauer, César Fernández, Martin Schröder, Martin Renatus
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field. ACS medicinal chemistry letters 14 (7) (2023)
Wouter Heyndrickx, Lewis H Mervin, Tobias Morawietz, Noé Sturm, Lukas Friedrich, Adam Zalewski, Anastasia Pentina, Lina Humbeck, Martijn Oldenhof, Ritsuya Niwayama, Peter Schmidtke, Nikolas Fechner, Jaak Simm, Adam Arany, Nicolas Drizard, Rama Jabal, Arina Afanasyeva, Regis Loeb, Shlok Verma, Simon Harnqvist, Matthew Holmes, Balazs Pejo, Maria Telenczuk, Nicholas Holway, Arne Dieckmann, Nicola Rieke, Friederike Zumsande, Djork-Arné Clevert, Michael Krug, Christopher Luscombe, Darren Green, Peter Ertl, Peter Antal, David Marcus, Nicolas Do Huu, Hideyoshi Fuji, Stephen D Pickett, Gergely Acs, Eric Boniface, Bernd Beck, Yax Sun, Arnaud Gohier, Friedrich Rippmann, Ola Engkvist, Andreas H Göller, Yves Moreau, Mathieu N Galtier, Ansgar Schuffenhauer, Hugo Ceulemans
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information. Journal of chemical information and modeling (2023)
Jaak Simm, Lina Humbeck, Adam Zalewski, Noe Sturm, Wouter Heyndrickx, Yves Moreau, Bernd Beck, Ansgar Schuffenhauer
Splitting chemical structure data sets for federated privacy-preserving machine learning. Journal of cheminformatics 13 (1) (2021)
Ansgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, Douglas S Auld, Jutta Blank, Simona Cotesta, Caroline Engeloch, Nikolas Fechner, Christoph Gaul, Jerome Giovannoni, Johanna M Jansen, John Joslin, Philipp Krastel, Eugen Lounkine, John Manchester, Lauren G Monovich, Anna Paola Pelliccioli, Manuel Schwarze, Michael D Shultz, Nikolaus Stiefl, Daniel K Baeschlin
Evolution of Novartis' Small Molecule Screening Deck Design. Journal of medicinal chemistry 63 (23) (2020)
Carole Pissot Soldermann, Oliver Simic, Martin Renatus, Paulus Erbel, Samu Melkko, Markus Wartmann, Marc Bigaud, Andreas Weiss, Paul McSheehy, Ralf Endres, Paulo Santos, Jutta Blank, Ansgar Schuffenhauer, Guido Bold, Nicole Buschmann, Thomas Zoller, Eva Altmann, Paul W Manley, Ina Dix, Elisabeth Buchdunger, Julien Scesa, Jean Quancard, Achim Schlapbach, Frédéric Bornancin, Thomas Radimerski, Catherine H Régnier
Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing. Journal of medicinal chemistry 63 (23) (2020)

Ansgar Schuffenhauer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ansgar Schuffenhauer